Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Liu, Yan'e"'
Autor:
Tian, Zhenyu1 (AUTHOR) tzy003@126.com, Liu, Yan'e2 (AUTHOR) liuyane0722@163.com, Zhu, Dan1 (AUTHOR) andrea_zhu@163.com, Cao, Baoshan2 (AUTHOR) caobaoshan0711@aliyun.com, Cui, Ming1 (AUTHOR) caobaoshan0711@aliyun.com
Publikováno v:
Journal of Clinical Medicine. Jan2024, Vol. 13 Issue 2, p529. 20p.
Autor:
Li Qian, Zhang Zhaohui, Xu Yaping, Liu Zhentian, Liu Zhentao, Wang Qiqi, Gu Yangchun, Liu Yan'e, Yin Wencheng, Yi Fumei, Yao Yanhong, Cao Baoshan, Liang Li
Publikováno v:
Thoracic Cancer, Vol 12, Iss 7, Pp 997-1005 (2021)
Abstract Background The tumor microenvironment is associated with prognosis in advanced non‐small cell lung carcinoma (NSCLC). The aim of this study was to explore the relationship between blood T cell diversity and survival of patients treated wit
Externí odkaz:
https://doaj.org/article/3c6485b0183e418680c2fa381e51666b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Liu, Yan'e1 (AUTHOR), Yao, Yanhong1 (AUTHOR), Wang, Qiqi1 (AUTHOR), Liu, Zhentao1 (AUTHOR), Gu, Yangchun1 (AUTHOR), Zhang, Hua2 (AUTHOR), Yi, Fumei1 (AUTHOR), Cao, Baoshan1 (AUTHOR) caobaoshan0711@aliyun.com
Publikováno v:
Asia Pacific Journal of Clinical Oncology. Oct2022, Vol. 18 Issue 5, pe338-e345. 8p.
Autor:
Liu, Yan'e1 (AUTHOR), Zhang, Jie2,3 (AUTHOR), Yin, Zhongnan2,3 (AUTHOR), Zhu, Xiang4 (AUTHOR), Xue, Lixiang2,3 (AUTHOR) lixiangxue@hsc.pku.edu.cn, Cao, Baoshan1 (AUTHOR) caobaoshan0711@aliyun.com
Publikováno v:
Thoracic Cancer. Jul2020, Vol. 11 Issue 7, p2023-2030. 8p.
Autor:
Liu Yan'e, Yin Wencheng, Cao Baoshan, Gu Yangchun, Yao Yanhong, Liang Li, Zhang Zhaohui, Li Qian, Wang Qiqi, Liu Zhentian, Yi Fumei, Xu Yaping, Liu Zhentao
Publikováno v:
Thoracic Cancer, Vol 12, Iss 7, Pp 997-1005 (2021)
Thoracic Cancer
Thoracic Cancer
Background The tumor microenvironment is associated with prognosis in advanced non‐small cell lung carcinoma (NSCLC). The aim of this study was to explore the relationship between blood T cell diversity and survival of patients treated with pemetre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2be7751b8af6899420de6a2fa10c3b7
https://doaj.org/article/3c6485b0183e418680c2fa381e51666b
https://doaj.org/article/3c6485b0183e418680c2fa381e51666b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Li Q; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Sun T; Department of General Surgery, Peking University Third Hospital, Beijing 100191, China., Zhang H; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China., Liu W; Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China., Xiao Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Sun H; Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China., Yin W; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Yao Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Gu Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Liu Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Yi F; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Wang Q; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Yu J; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Cao B; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Liang L; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Publikováno v:
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 Mar 20; Vol. 25 (3), pp. 137-146.
Autor:
Yin W; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Zhang H; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing 100191, China., Gu Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Yi F; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Li Q; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Liu Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Yao Y; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Liu Z; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China., Cao B; Department of Medical Oncology and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
Publikováno v:
Zhongguo fei ai za zhi = Chinese journal of lung cancer [Zhongguo Fei Ai Za Zhi] 2022 Mar 20; Vol. 25 (3), pp. 156-166.